The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
The mucosal immune system: from fundamental concepts to vaccine development
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., & Kiyono, H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90021-b · Cited by 903
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Biodegradable microspheres as a vaccine delivery system
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., & Gilley, R. M. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90076-v · Cited by 399
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06377.x · Cited by 394
Nanoparticles--a new colloidal drug delivery system.
Marty, J. J., Oppenheim, R. C., & Speiser, P. P. (1978) · PubMed · Cited by 337
Illum, L., Davis, S. S., Müller, R. H., Mak, E., & West, P. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90138-x · Cited by 273
Nanocapsules as carriers for oral peptide delivery
Damgé, C., Michel, C., Aprahamian, M., Couvreur, P., & Devissaguet, J. P. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90013-j · Cited by 245
Pappo, J., & Ermak, T. H. (1989) · PubMed Central · Cited by 216
Couvreur, P., Kante, B., Roland, M., & Speiser, P. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681215 · Cited by 186
Cited by
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Self-citationNanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
“The efficiency of uptake of 100 nm size particles was 15–250 fold greater than larger size (1 and 10 μm) microparticles [9].”
BackgroundNanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationFood protein-based materials as nutraceutical delivery systems
Chen, L., Remondetto, G. E., & Subirade, M. (2006) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2005.12.011 · Cited by 1,160
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
“Studies have reported that NPs are more effective than microparticles as drug carriers [183].”
BackgroundNanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,054
Applications and implications of nanotechnologies for the food sector
Chaudhry, Q., Scotter, M., Blackburn, J., Ross, B., Boxall, A., Castle, L., Aitken, R., & Watkins, R. (2008) · Food Additives & Contaminants: Part A · doi:10.1080/02652030701744538 · Cited by 1,051
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Gan, Q., Wang, T., Cochrane, C., & McCarron, P. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.06.001 · Cited by 908
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 874
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Self-citationParticokinetics In Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments
Teeguarden, J. G., Hinderliter, P. M., Orr, G., Thrall, B. D., & Pounds, J. G. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl165 · Cited by 765
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Wilson, D. S., Dalmasso, G., Wang, L., Sitaraman, S. V., Merlin, D., & Murthy, N. (2010) · Nature Materials · doi:10.1038/nmat2859 · Cited by 747
Hillyer, J. F., & Albrecht, R. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1143 · Cited by 706
Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00152-1 · Cited by 680
Arifin, D. Y., Lee, L. Y., & Wang, C.-H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.007 · Cited by 674
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Xu, M., Qi, Y., Liu, G., Song, Y., Jiang, X., & Du, B. (2023) · ACS Nano · doi:10.1021/acsnano.3c05853 · Cited by 632
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Nam, H. Y., Kwon, S. M., Chung, H., Lee, S.-Y., Kwon, S.-H., Jeon, H., Kim, Y., Park, J. H., Kim, J., Her, S., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.018 · Cited by 564
Nanostructure-mediated drug delivery
Hughes, G. A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2004.11.009 · Cited by 561
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
Self-citationHua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Self-citationChitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Nanoparticles synthesis using supercritical fluid technology – towards biomedical applications
Byrappa, K., Ohara, S., & Adschiri, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.001 · Cited by 487
Solid Lipid Nanoparticles as Delivery Systems for Bioactive Food Components
Weiss, J., Decker, E. A., McClements, D. J., Kristbergsson, K., Helgason, T., & Awad, T. (2008) · Food Biophysics · doi:10.1007/s11483-008-9065-8 · Cited by 474
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
Chen, M.-C., Mi, F.-L., Liao, Z.-X., Hsiao, C.-W., Sonaje, K., Chung, M.-F., Hsu, L.-W., & Sung, H.-W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.010 · Cited by 451
Yin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 447
Green approach for nanoparticle biosynthesis by fungi: current trends and applications
Dhillon, G. S., Brar, S. K., Kaur, S., & Verma, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2010.550568 · Cited by 445
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Silk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems
Semete, B., Booysen, L., Lemmer, Y., Kalombo, L., Katata, L., Verschoor, J., & Swai, H. S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.02.002 · Cited by 425
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M.-C., Sonaje, K., Chen, K.-J., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 420
Amidi, M., Romeijn, S. G., Borchard, G., Junginger, H. E., Hennink, W. E., & Jiskoot, W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.014 · Cited by 415
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Cartiera, M. S., Johnson, K. M., Rajendran, V., Caplan, M. J., & Saltzman, W. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.057 · Cited by 412
“NPs were prepared using a single-emulsion technique [7,18].”
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Review of polysaccharide particle-based functional drug delivery
Barclay, T. G., Day, C. M., Petrovsky, N., & Garg, S. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.05.067 · Cited by 396
Lomer, M. C. E., Thompson, R. P. H., & Powell, J. J. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2001134 · Cited by 381
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Feng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Peters, R., Kramer, E., Oomen, A. G., Herrera Rivera, Z. E., Oegema, G., Tromp, P. C., Fokkink, R., Rietveld, A., Marvin, H. J. P., Weigel, S., et al. (2012) · ACS Nano · doi:10.1021/nn204728k · Cited by 336
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Self-citationCheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H. L., & Baum, L. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9444-4 · Cited by 314
Nanomedicines for overcoming biological barriers
José Alonso, M. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications
Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01098 · Cited by 308
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
Production and characterization of Hesperetin nanosuspensions for dermal delivery
Mishra, P. R., Shaal, L. A., Müller, R. H., & Keck, C. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.030 · Cited by 308
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Self-citationNanoparticles: Oral Delivery for Protein and Peptide Drugs
Cao, S.-J., Xu, S., Wang, H.-M., Ling, Y., Dong, J., Xia, R.-D., & Sun, X.-H. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1325-z · Cited by 305
Chitosan nanoparticles: a survey of preparation methods
Grenha, A. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.654121 · Cited by 305
Models for oral uptake of nanoparticles in consumer products
Fröhlich, E., & Roblegg, E. (2012) · Toxicology · doi:10.1016/j.tox.2011.11.004 · Cited by 295
Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y.-X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 293
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
de Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Self-folding polymeric containers for encapsulation and delivery of drugs
Fernandes, R., & Gracias, D. H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.012 · Cited by 285
In vitro and in vivo models for the study of oral delivery of nanoparticles
Gamboa, J. M., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.003 · Cited by 285
Kanchan, V., & Panda, A. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.015 · Cited by 283
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Self-citationPolymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Wong, C. Y., Al-Salami, H., & Dass, C. R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.036 · Cited by 269
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.010 · Cited by 265
Nanoparticle Technology for Drug Delivery
(2006) · CRC Press eBooks · doi:10.1201/9780849374555 · Cited by 264
Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells
Gerloff, K., Albrecht, C., Boots, A. W., Förster, I., & Schins, R. P. F. (2009) · Nanotoxicology · doi:10.3109/17435390903276933 · Cited by 263
The effect of physical barriers and properties on the oral absorption of particulates
Norris, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00037-4 · Cited by 262
Sahana, D. K., Mittal, G., Bhardwaj, V., & Kumar, M. N. V. R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21158 · Cited by 260
Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia
McClean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, N., Ramtoola, Z., & Brayden, D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10007-0 · Cited by 260
Oral Bioavailability of Insulin Contained in Polysaccharide Nanoparticles
Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., & Neufeld, R. (2007) · Biomacromolecules · doi:10.1021/bm0703923 · Cited by 260
Haidar, Z. S., Hamdy, R. C., & Tabrizian, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.012 · Cited by 260
Floating dosage forms: an in vivo study demonstrating prolonged gastric retention
Whitehead, L., Fell, J. T., Collett, J. H., Sharma, H. L., & Smith, A.-M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00266-6 · Cited by 259
Kawakami, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.009 · Cited by 259
Metadata
- Authors
- Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J.
- Venue
- Pharmaceutical Research
- Published
- 1996-12
- Volume
- 13
- Issue
- 12
- Pages
- 1838-1845
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1486016704
- Cited by
- 941
- References
- 24
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.